SCHEMBL2966914

SCHEMBL2966914

CCCCc1ccc(-c2cc(Br)c3c(c2)C(C)C=C3)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 8/20 0.38
AKR1C2 P52895 1/20 0.36
AKR1C1 Q04828 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
NPC1 O15118 2/20 0.35
NFKB1 P19838 2/20 0.35
RAB9A P51151 2/20 0.35
NFKB2 Q00653 2/20 0.35
RELA Q04206 2/20 0.35
MAPK1 P28482 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
ALDH1A1 P00352 3/20 0.35
HSD17B10 Q99714 2/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
FDFT1 P37268 1/20 0.34
RARA P10276 2/20 0.34
MAPT P10636 2/20 0.34
CA2 P00918 1/20 0.34
SKP2 Q13309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2971776 0.81 NPC1 (0.37) RARBSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL2967851 0.79 RARB (0.38) RARBAKR1C2AKR1C1SMN1; SMN2NPC1
SCHEMBL2971789 0.79 RARB (0.35) RARBSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL2970693 0.76 RARB (0.35) RARBSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL2966215 0.75 RARB (0.35) RARBSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL2972301 0.75 RARB (0.35) RARBSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL2958506 0.74 RARB (0.35) RARBSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL2972328 0.74 RARB (0.35) RARBSMN1; SMN2NPC1NFKB1RAB9A
SCHEMBL12128088 0.74 RARB (0.49) RARBAKR1C2AKR1C1SMN1; SMN2NPC1
SCHEMBL11303903 0.72 RARB (0.50) RARBAKR1C2AKR1C1SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 RARB 2436/4885AKR1C2 3868/4885AKR1C1 4022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.